KDR and colorectal carcinoma: tested a cocktail vaccine consisting of five peptides [RNF43-721, TOMM34-299, KOC1(IMP-3)-508, VEGFR1-1084, and VEGFR2-169] in combination with oxaliplatin (FOLFOX, XELOX) in their phase II clinical trial among patients with advanced CRC (47).